[go: up one dir, main page]

WO2009063576A1 - Agent anticancéreux - Google Patents

Agent anticancéreux Download PDF

Info

Publication number
WO2009063576A1
WO2009063576A1 PCT/JP2008/001103 JP2008001103W WO2009063576A1 WO 2009063576 A1 WO2009063576 A1 WO 2009063576A1 JP 2008001103 W JP2008001103 W JP 2008001103W WO 2009063576 A1 WO2009063576 A1 WO 2009063576A1
Authority
WO
WIPO (PCT)
Prior art keywords
anticancer agent
extract
rhus
leaf
safe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/001103
Other languages
English (en)
Japanese (ja)
Inventor
Yoshihiro Sekino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP08751628.2A priority Critical patent/EP2105140B1/fr
Priority to US12/523,111 priority patent/US20100068317A1/en
Priority to JP2009541016A priority patent/JP5840346B2/ja
Publication of WO2009063576A1 publication Critical patent/WO2009063576A1/fr
Anticipated expiration legal-status Critical
Priority to US13/466,918 priority patent/US8852658B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Agent anticancéreux caractérisé en ce qu'il renferme la fleur de l'orme ou son extrait et la feuille de sumac ou son extrait. Cet agent anticancéreux est sans risque et présente une activité élevée.
PCT/JP2008/001103 2007-11-15 2008-04-25 Agent anticancéreux Ceased WO2009063576A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP08751628.2A EP2105140B1 (fr) 2007-11-15 2008-04-25 Agent anticancéreux comprenant ulmus hollandica et rhus verniciflua
US12/523,111 US20100068317A1 (en) 2007-11-15 2008-04-25 Anticancer composition
JP2009541016A JP5840346B2 (ja) 2007-11-15 2008-04-25 抗癌剤
US13/466,918 US8852658B2 (en) 2007-11-15 2012-05-08 Anticancer composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007296553 2007-11-15
JP2007-296553 2007-11-15

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/523,111 A-371-Of-International US20100068317A1 (en) 2007-11-15 2008-04-25 Anticancer composition
US13/466,918 Division US8852658B2 (en) 2007-11-15 2012-05-08 Anticancer composition

Publications (1)

Publication Number Publication Date
WO2009063576A1 true WO2009063576A1 (fr) 2009-05-22

Family

ID=40638432

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/001103 Ceased WO2009063576A1 (fr) 2007-11-15 2008-04-25 Agent anticancéreux

Country Status (4)

Country Link
US (2) US20100068317A1 (fr)
EP (1) EP2105140B1 (fr)
JP (1) JP5840346B2 (fr)
WO (1) WO2009063576A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010265203A (ja) * 2009-05-13 2010-11-25 Kibun Foods Inc 貧血治療剤
JP2012025666A (ja) * 2010-07-20 2012-02-09 Hoashi Masahito 副作用低減剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119112927B (zh) * 2024-10-10 2025-08-05 北京市肿瘤防治研究所 包含万寿菊苷的抗食管鳞癌药物组合物及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11130688A (ja) * 1997-10-23 1999-05-18 Hoashi Masahito 逆転写酵素阻害剤
US6267993B1 (en) 1994-01-20 2001-07-31 Masahito Hoashi Plant-derived powder and an extract of the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100257448B1 (ko) * 1997-08-01 2000-07-01 박홍락 항암, 기관분화유도, 암세포전이 혈관형성억제, 항산화 및 숙취해소 작용을 하는 옻나무 추출물, 이의 제조방법 및 이를 포함하는 조성물
JP2003231641A (ja) * 2003-03-07 2003-08-19 Hoashi Masahito 肝機能障害の予防または治療用の医薬組成物
KR20050003321A (ko) * 2003-06-28 2005-01-10 박평일 암, 노화방지, 느릅나무 백년약즙
KR20050107352A (ko) * 2005-10-25 2005-11-11 (주)에이지아이 옻나무 추출물을 이용한 신규의 천연물 항암제

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267993B1 (en) 1994-01-20 2001-07-31 Masahito Hoashi Plant-derived powder and an extract of the same
JPH11130688A (ja) * 1997-10-23 1999-05-18 Hoashi Masahito 逆転写酵素阻害剤
EP0934747A1 (fr) 1997-10-23 1999-08-11 Hoashi, Masahito Inhibiteur de la transcriptase inverse a partir de Ulmus Hollandica

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"ACS Symp Ser", 1994, AM CHEM SOC, article PERCHELLET J P ET AL.: "Antitumor-Promoting Effects of Gallotannins, Ellagitannins, and Flavonoids in Mouse Skin In Vivo", pages: 303 - 327, XP008109699 *
See also references of EP2105140A4
WANG D ET AL.: "Cytotoxic Effects of Mansonone E and F Isolated from Ulmus pumila", BIOL PHARM BULL, vol. 27, no. 7, 2004, pages 1025 - 1030, XP015001550 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010265203A (ja) * 2009-05-13 2010-11-25 Kibun Foods Inc 貧血治療剤
JP2012025666A (ja) * 2010-07-20 2012-02-09 Hoashi Masahito 副作用低減剤

Also Published As

Publication number Publication date
US20120251644A1 (en) 2012-10-04
US20100068317A1 (en) 2010-03-18
US8852658B2 (en) 2014-10-07
JPWO2009063576A1 (ja) 2011-03-31
EP2105140B1 (fr) 2014-01-22
EP2105140A1 (fr) 2009-09-30
EP2105140A4 (fr) 2010-01-27
JP5840346B2 (ja) 2016-01-06

Similar Documents

Publication Publication Date Title
AU2009216012A8 (en) Leaves extract of Panax SP., a process of making the same and uses thereof
WO2007109804A3 (fr) Extraits de l'espèce cannelle et méthodes de préparation de ces derniers
EP1806157B8 (fr) Appareil d'aerosoltherapie
WO2008005705A3 (fr) Formulations à teneur métallique et procédés d'utilisation
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
AP2011005776A0 (en) Pharmaceutical composition comprising linagliptin and optionally a SGLT2 inhibitor, and uses thereof.
WO2010118866A8 (fr) Composition contenant du trehalulose, sa preparation et son utilisation
EP2095718A4 (fr) Extrait de thé
WO2009027849A3 (fr) Extrait de goyave
EP2150233A4 (fr) Isolats antimicrobiens et anti-inflammatoires d'extrait de réglisse
WO2009007532A3 (fr) Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
WO2007144521A3 (fr) Composition cosmetique a usage topique comprenant du wasabi
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2009047443A3 (fr) Composition cosmétique destinée à améliorer l'état de la peau
USD644262S1 (en) Type font
WO2009063576A1 (fr) Agent anticancéreux
WO2010011997A3 (fr) Compositions comprenant un extrait de docynia delavajy et/ou un extrait d'elaeagnus lancelotus extract
IL195096A0 (en) Aqueous tobacco leaf extract, uses thereof in the treatment of dependence
EP2217257A4 (fr) Extrait de plante standardisé, procédé d'obtention dudit extrait et utilisations dudit extrait
WO2009078931A9 (fr) Facteur de régulation de l'interféron (irf) en tant que suppresseur de tumeurs et ses utilisations
WO2011140226A3 (fr) Compositions comprenant des extraits d'aurone mâle et un composé amine
WO2006105502A3 (fr) Catheter
WO2007009989A3 (fr) COMPOSITION COMPRENANT UNE DISPERSION LIPOSOMALE DE NANOPARTICULES DE SIO2 ET UN DERIVE D'ETHER DE GLUCANE A LIAISON ß-1,3
WO2007140804A8 (fr) Procédé de préparation d'un oxaliplatine
WO2009080004A3 (fr) Produit pour le sevrage tabagique

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 12523111

Country of ref document: US

Ref document number: 2008751628

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08751628

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009541016

Country of ref document: JP